Motley FoolAdventures in CAR-T Racing: Crashes and Curves EditionMotley FoolJust eight days after Juno Therapeutics announced its setback, bluebird bio shared some positive data for bb2121, a CAR-T therapy that reengineers T-cells to target B-cell matu… Continue reading
Proactive Investors UK |
WideCells signs LOI with Qigenix to undertake research at Manchester stem cell facility
News-Medical.net WideCells Group PLC, the healthcare services company focused on providing stem cell banking services and ground breaking insurance for stem cell treatment, is pleased to announce that it has taken steps to secure a new revenue stream, in addition to … Partnership ‘opens up second revenue stream’ for Widecells’ research facilityProactive Investors UK |
Proactive Investors UK |
WideCells signs LOI with Qigenix to undertake research at Manchester stem cell facility
News-Medical.net WideCells Group PLC, the healthcare services company focused on providing stem cell banking services and ground breaking insurance for stem cell treatment, is pleased to announce that it has taken steps to secure a new revenue stream, in addition to … Partnership ‘opens up second revenue stream’ for Widecells’ research facilityProactive Investors UK |
3DPrint.com |
Celprogen 3D Prints a Pancreas from PLA and Human Stem Cells
3DPrint.com Stem cell research company Celprogen Inc. has announced that they have successfully 3D printed a human pancreas from PLA seeded with adult human pancreatic stem cells. It’s the second major announcement within a few months from Celprogen, which … |
Times of India |
Sawai Man Singh Hospital conducts stem cell transplant on Nigerian national
Times of India Dr Jasuja said that they conducted autologous stem cell transplant on the patient. “There are three kinds of stem cell transplants — allogeneic transplant, autologous transplant and haploidentical transplant. In allogeneic transplant, doctors take … |
Investing News Network (press release) (registration) (blog) |
Is the Stem Cell Market Heating Up? Acquisition Activity Suggests Yes.
Investing News Network (press release) (registration) (blog) Are stem cell securities a fool’s game? A decade ago, the answer from unlucky investors may have been a resounding yes. Back then, hot companies went bankrupt, others devalued as much as 99 percent. And that led select investors to swear off stem cell … |
Phys.Org |
Neural stem cells serve as RNA highways too
Phys.Org “The moving molecules we saw in these stem cells could be crucial for their function—including their decision to become neurons,” said the study’s senior investigator Debra Silver, an assistant professor of molecular genetics and microbiology at the … |